About Petr Sramek
Petr Sramek is a director at Klothea Bio.
Form D filings also name Petr Sramek as a director at Animal Bioscience.
Petr Sramek first appears on SEC filings in 2020.
Experience
This experience comes from Petr Sramek's profile and from SEC filings. For roles taken from filings, the years are when the filings name Petr Sramek in the role, so the role may have started earlier or lasted longer.
Klothea Bio, Inc. Current
Director
2024 – Present · Miami, FL
Develops experimental treatments for people affected by age-related diseases.
HC
HealthyLongevity.clinic Current
Chief Executive Officer
2021 – Present
Animal Biosciences, Inc. Current
Director
2020 – Present · Boston, MA
Develops supplements and treatments for aging pets, including dogs.
HC
HealthyLongevity.cafe Current
Founder and Executive Chairman
2020 – Present
LE
LongevityForum.eu Current
Co-Founder
2020 – Present
LF
Longevitytech.fund Current
Managing Partner
2019 – Present
WH
Whytics Current
Founder and Lead Scientist
2019 – Present
LP
LightED Play Current
Advisory Board Member
2019 – Present
GO
GoodAI Current
Strategic Advisor
2019 – Present
CT
Celeris Therapeutics
Board Member
2021 – 2023
HG
HealthyLongevity.guide
Executive Chairman
2021 – 2023
WF
World Business Angels Investment Forum
WBAF Senator Czech Republic
2018 – 2021
SU
Singularity University
Entrepreneur In Residence
2019 – 2020
FI
Founder Institute
Mentor
2019 – 2020
AA
AI Awards
Chairman of the jury
2018 – 2020
AG
AI Path to Growth
AI Startups and VC Advisory, Fundraising, Strategy, Evaluation
2018 – 2020
AI
AI Startup Incubator
Founder
2017 – 2020
NS
Neuron soundware
Advisory Board Member
2018 – 2019
PP
PACTUM.PRO
CEO
2017
BG
BenchCom Group
CTO and founder
2004 – 2017
Key Colleagues at Startups
The people Petr Sramek works with at each company, as listed on that company's latest Form D.
Animal Biosciences, Inc. · Form D, Sep 9, 2026
Jared Barlow
Director
Virginia Rentko
CEO/Chief Veterinary Medical Officer and director
Nicholas Sinclair
Director
Klothea Bio, Inc. · Form D/A, Sep 8, 2026
OJ
Olivier Jarry
Executive officer
WS
Walter Schmidt
Director
AI
Agustin Fernandez Santana III
Executive officer and director
JM
Jeffrey Madden
President and director